The Need for Individualized Risk Assessment in Cardiovascular Disease
Cardiovascular disease remains the leading cause of death in the era of modern medicine despite major advancements in this field. Current available clinical surrogate markers and blood tests do not adequately predict individual risk of cardiovascular disease. A more precise and sophisticated tool th...
Main Authors: | Hui Yin Lim, Louise M. Burrell, Rowena Brook, Harshal H. Nandurkar, Geoffrey Donnan, Prahlad Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/7/1140 |
Similar Items
-
Virchow’s Triad and the Role of Thrombosis in COVID-Related Stroke
by: Francisco J. Gonzalez-Gonzalez, et al.
Published: (2021-11-01) -
The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow’s Triad
by: Aina Anton, et al.
Published: (2022-02-01) -
Effect of Carbon Dioxide Pneumo-peritoneum in Coagulation Profile of Patients undergoing Laparoscopic Cholecystectomy: A Prospective Cohort Study
by: Chabungbam Gyan Singh, et al.
Published: (2024-03-01) -
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
by: Hui Yin Lim, et al.
Published: (2022-09-01) -
Approach to: Venous Thromboembolism
by: Salima Ramdani
Published: (2022-10-01)